Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released Mar 8, 2019, after the close
10-K filed Mar 8, 2019, 67 days after period end · 0001558370-19-001698
| Metric | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|
| Net Income | -$25.51M | -$10.53M | -$8.37M |
| EPS Diluted | -$0.74 | -$0.41 | -$0.90 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2018 · filed Mar 8, 2019 · 67 d after period end
+7.0% from the close of Mar 7, 2019 to the close of Mar 12, 2019, the first after the release.